Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome-Reference-Cited by-同舟云学术

Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome

Published:2021-11-15 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

von Groote Thilo C¹,Williams Gabrielle²,Au Eric H³⁴⁵,Chen Yizhi⁶⁷,Mathew Anna T⁸,Hodson Elisabeth M⁹,Tunnicliffe David J³

Affiliation:

1. Department of Anaesthesiology, Intensive Care and Pain Medicine; University Hosptial Münster; Münster Germany

2. Analytics Assist; NSW Ministry of Health; North Sydney Australia

3. Sydney School of Public Health; The University of Sydney; Sydney Australia

4. Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

5. Department of Renal Medicine; Westmead Hospital; Westmead Australia

6. Department of Nephrology, Hainan Hospital of Chinese PLA General Hospital; Hainan Provincial Academician Team Innovation Center; Sanya China

7. Senior Department of Nephrology, the First Medical Center of Chinese PLA General Hospital; Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research; Beijing China

8. Department of Nephrology; McMaster University; Hamilton Canada

9. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference238 articles.

1. Prospective study to compare efficacy of tacrolimus versus cyclophosphamide in inducing remission in idiopathic membranous nephropathy [abstract no: SA-PO357];Agarwal;Journal of the American Society of Nephrology,2012

2. Methyl prednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy - a preliminary study;Ahmed;Bangladesh Renal Journal,1994

3. Rahman M Ahmed S Alam MR Selim SI Chowdhury MN Chowdhury SM Methyl prednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy - a preliminary study [abstract] 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 66

4. Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy (IMN): preliminary baseline and pharmacokinetic (PK)/pharmacodynamic (PD) data [abstract no: SU-PO970];Appel;Journal of the American Society of Nephrology,2002

5. Lipoprotein-(a)[Lp(a)] levels in nephrotic syndrome [NS] [abstract no: A0642];Radhakrishnan;Journal of the American Society of Nephrology,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efectividad del tratamiento y manejo de la glomerulonefritis membranosa en pacientes adultos;ConcienciaDigital;2023-10-05

2. Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy;Clinical and Experimental Medicine;2023-09-09

3. Efficacy and safety of Danggui Niantong Decoction in patients with gout: a systematic review and meta-analysis;Frontiers in Pharmacology;2023-07-26

4. A new approach to immunosuppressive therapy in patients with glomerulonephritis with nephrotic syndrome;Medical Immunology (Russia);2023-06-13

5. Efficacy and safety of mizoribine in comparison with cyclophosphamide for treatment of lupus nephritis: Protocol for a multi-center, open-label, randomized controlled trial;F1000Research;2023-06-07